Cite
HARVARD Citation
Puthenparampil, M. et al. (2018). NEDA-3 status including cortical lesions in the comparative evaluation of natalizumab versus fingolimod efficacy in multiple sclerosis. Therapeutic advances in neurological disorders. p. . [Online].